Skip to content

An investigation on the effect of glucosamine intake on gut environments

An investigation on the effect of glucosamine intake on gut environments - A double-blind crossover placebo-controlled study - - Effect of glucosamine on gut environments - A double-blind crossover placebo-controlled study -

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000058908
Enrollment
40
Registered
2025-12-07
Start date
2025-08-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constipation tendency in adults

Interventions

Intake of glucosamine 3000mg per day for 14 days Intake of placebo 3000mg per day for 14 days

Sponsors

SOUKEN Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Japanese men and women aged 20 to 59 years at the time of consent. 2) Individuals capable of consistently taking 10 or more supplement tablets per day (can be divided into multiple doses). 3) Individuals with a bowel movement frequency of 3 to 5 times per week. 4) Individuals able to store stool samples collected at home in their refrigerator or freezer for several days until their visit.

Exclusion criteria

Exclusion criteria: 1) Individuals with alcohol dependency 2) Individuals taking medications that may influence the study results (e.g., drugs with intestinal regulatory effects, antibiotics, etc.) 3) Individuals routinely consuming health foods that may affect the study results (e.g., supplements containing lactic acid bacteria, oligosaccharides, or those claiming intestinal regulatory effects) 4) Individuals with potential allergy symptoms to test product components (especially shrimp or crab) 5) Individuals participating in other clinical trials 6) Individuals with a history of severe liver, kidney, or heart disease 7) Individuals with a history or current diagnosis of hepatitis 8) Individuals with a history or current diagnosis of diabetes 9) Individuals with a history or current diagnosis of thrombosis 10) Individuals with severe anemia 11) Pregnant women, women who may be pregnant, and breastfeeding women

Design outcomes

Primary

MeasureTime frame
Gut environment parameters

Secondary

MeasureTime frame
Blood biochemistry parameters

Countries

Japan

Contacts

Public ContactTomoya Shintani

TOYO INSTITUTE of FOOD TECHNOLOGY Research department

tomoya_shintani@shokuken.or.jp08072169232

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026